▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁is 5.578125
▁still 6.25390625
▁considered 5.02734375
▁to 1.732421875
▁be 0.45458984375
▁an 3.00390625
▁extreme 5.94140625
▁issue 7.3671875
▁among 7.3359375
▁at 6.828125
▁least 1.4111328125
▁ 2.65234375
8 3.193359375
% 4.31640625
▁of 1.8515625
▁the 1.2392578125
▁residents 6.890625
▁of 2.291015625
▁progress 9.421875
ive 0.9921875
▁countries 6.890625
. 2.109375
▁The 2.50390625
▁introduction 7.234375
▁of 0.25732421875
▁the 1.6083984375
▁study 6.7890625
▁describes 8.03125
▁the 0.86572265625
▁apparent 9.0625
▁link 6.32421875
▁between 0.53515625
▁pain 6.265625
▁and 0.7451171875
▁dem 8.375
oral 3.49609375
ization 0.281982421875
. 1.4580078125
▁Chron 6.2421875
ic 0.02850341796875
▁pain 0.310302734375
▁is 1.3017578125
▁always 6.38671875
▁accompanied 2.185546875
▁by 0.058624267578125
▁negative 4.90234375
▁emot 1.478515625
ional 1.326171875
▁experiences 2.97265625
▁and 2.126953125
▁blocks 11.046875
▁a 4.15234375
▁person 1.40234375
’ 24.875
s 1.970703125
▁ability 1.8466796875
▁to 0.04730224609375
▁receive 6.29296875
▁joy 4.90625
▁and 1.3916015625
▁satisfaction 3.033203125
▁from 1.212890625
▁life 1.03125
. 0.324951171875
▁The 1.888671875
▁research 3.91796875
▁investig 5.296875
ates 0.46044921875
▁the 0.483642578125
▁development 5.91796875
▁of 0.17578125
▁de 3.837890625
pression 0.253173828125
▁and 1.283203125
▁anx 2.255859375
iety 0.004970550537109375
▁among 2.369140625
▁patients 2.45703125
▁receiving 4.48828125
▁ph 6.6171875
arma 1.7861328125
ce 0.0086822509765625
ut 0.0004546642303466797
ical 0.01073455810546875
▁op 5.04296875
io 0.1884765625
ids 0.6259765625
▁and 2.3828125
▁medical 6.171875
▁mar 1.4921875
iju 0.04852294921875
ana 0.0001990795135498047
▁( 4.38671875
MM 0.68212890625
) 3.4765625
▁as 2.841796875
▁severe 9.9375
▁pain 1.609375
kill 3.0625
ers 0.0019044876098632812
. 0.5302734375
▁It 3.234375
▁comp 5.125
ares 0.05218505859375
▁the 0.63037109375
▁effic 6.4140625
acy 0.0082855224609375
▁of 0.277587890625
▁pres 5.109375
cri 1.755859375
ptions 0.6923828125
▁and 2.302734375
▁exam 5.81640625
ines 0.011260986328125
▁the 0.44970703125
▁possibility 3.80078125
▁of 0.10784912109375
▁post 7.1953125
- 0.6748046875
tre 2.501953125
at 0.02496337890625
ment 0.00732421875
▁de 1.826171875
pression 0.10284423828125
. 1.7509765625
<0x0A> 2.302734375
There 4.90625
▁is 1.0654296875
▁currently 4.5859375
▁a 1.1552734375
▁severe 4.9140625
▁lack 3.28125
▁of 0.026031494140625
▁information 2.103515625
▁about 1.4140625
▁the 0.475341796875
▁effects 2.9140625
▁of 0.07513427734375
▁op 1.814453125
i 3.98046875
ates 0.11663818359375
. 3.83203125
▁They 4.8984375
▁manage 8.859375
▁pain 3.55859375
▁successfully 5.82421875
, 1.0283203125
▁but 0.32666015625
▁the 2.62890625
▁past 9.5390625
▁few 2.521484375
▁dec 0.79052734375
ades 7.2479248046875e-05
▁indicated 9.671875
▁the 2.0390625
▁growing 4.66015625
▁concern 3.583984375
▁regarding 2.787109375
▁op 3.6171875
iate 0.6953125
▁ab 1.533203125
use 0.00826263427734375
▁in 3.427734375
▁forms 10.5234375
▁of 0.4013671875
▁over 3.302734375
d 0.3505859375
ose 0.186279296875
▁and 0.69921875
▁add 1.1142578125
iction 0.0269927978515625
. 0.20458984375
▁A 3.986328125
▁more 5.71484375
▁manage 8.9921875
able 0.0037078857421875
▁and 2.24609375
▁sa 2.283203125
fer 7.796287536621094e-05
▁alternative 1.6640625
▁might 6.40625
▁be 0.18994140625
▁medical 2.6875
▁mar 0.1785888671875
iju 0.0036640167236328125
ana 0.0005507469177246094
. 1.5146484375
▁However 2.90625
, 0.007232666015625
▁the 1.59375
▁legal 4.2421875
▁status 1.193359375
▁and 2.75390625
▁novel 9.140625
ty 0.66259765625
▁of 0.2100830078125
▁this 1.689453125
▁drug 2.08984375
▁do 5.02734375
▁not 0.07000732421875
▁allow 1.0283203125
▁finding 8.765625
▁a 2.337890625
▁large 4.375
▁number 1.439453125
▁of 0.0037899017333984375
▁studies 1.3271484375
▁on 1.5322265625
▁its 0.98095703125
▁effect 2.0625
iveness 0.442138671875
. 0.9619140625
▁Specifically 8.1953125
, 0.114501953125
▁it 2.728515625
▁concerns 4.8359375
▁the 0.646484375
▁emot 7.375
ional 0.0172576904296875
▁condition 5.36328125
▁of 0.3837890625
▁patients 0.720703125
▁experien 6.29296875
cing 3.445148468017578e-05
▁chron 1.134765625
ic 0.002315521240234375
▁pain 0.09808349609375
. 0.65380859375
▁This 3.1484375
▁research 2.994140625
▁paper 6.21484375
▁a 2.189453125
ims 0.00040721893310546875
▁to 0.0924072265625
▁analyze 3.064453125
▁levels 9.6640625
▁of 0.034210205078125
▁de 0.54736328125
pression 0.03619384765625
▁and 0.270263671875
▁anx 0.04241943359375
iety 0.0012149810791015625
▁among 0.796875
▁people 3.263671875
▁receiving 0.9501953125
▁ther 8.0078125
apy 0.33935546875
▁by 5.25390625
▁comparing 7.9375
▁the 0.98583984375
▁effects 2.16796875
▁of 0.0299530029296875
▁ph 2.453125
arma 0.03961181640625
ce 0.0011348724365234375
ut 7.11679458618164e-05
ical 0.003910064697265625
▁op 0.306640625
io 0.1646728515625
ids 0.05780029296875
▁and 0.279541015625
▁MM 1.21875
. 0.998046875
<0x0A> 1.005859375
The 1.3369140625
▁study 2.013671875
▁was 2.06640625
▁conducted 0.7421875
▁in 1.529296875
▁the 1.4462890625
▁form 2.203125
▁of 0.006290435791015625
▁collection 10.03125
▁and 1.689453125
▁analysis 0.6796875
▁of 0.045684814453125
▁statistical 4.203125
▁data 0.11993408203125
. 0.890625
▁Part 4.94921875
icip 0.06744384765625
ants 0.045074462890625
▁were 0.69970703125
▁rec 3.251953125
ru 0.001068115234375
ited 4.661083221435547e-05
▁for 4.0546875
▁six 7.55078125
▁months 0.5224609375
▁at 3.76171875
▁two 2.498046875
▁major 5.44921875
▁pain 3.076171875
▁relief 5.25
▁cent 1.548828125
ers 0.077880859375
▁in 0.70849609375
▁Israel 4.3203125
. 0.41357421875
▁The 1.1943359375
▁research 2.16796875
ers 1.505859375
▁used 2.701171875
▁The 8.0703125
▁De 4.21484375
pression 0.01316070556640625
▁Module 10.1328125
▁of 0.96044921875
▁the 0.32470703125
▁Pat 2.28515625
ient 0.00749969482421875
▁Health 0.084716796875
▁Question 0.01406097412109375
naire 0.0183258056640625
▁and 3.3515625
▁the 0.73046875
▁General 1.6845703125
ized 0.69091796875
▁An 0.0159912109375
x 0.00014460086822509766
iety 0.002685546875
▁Dis 0.51171875
order 0.034881591796875
▁Sc 1.2080078125
ale 0.0682373046875
▁to 1.740234375
▁interview 7.0703125
▁participants 2.015625
, 3.69921875
▁evaluate 5.56640625
▁their 0.744140625
▁answers 6.48828125
, 0.85498046875
▁and 0.1409912109375
▁conduct 4.4453125
▁the 2.30078125
▁study 2.2421875
. 0.22509765625
▁To 5.09765625
▁specifically 9.8828125
▁evaluate 2.578125
▁and 4.35546875
▁compare 0.94091796875
▁the 0.336669921875
▁prob 11.1328125
abilities 0.1783447265625
▁of 0.130126953125
▁de 0.82470703125
pression 0.037353515625
▁or 4.5859375
▁anx 0.035552978515625
iety 0.00029468536376953125
▁among 1.72265625
▁the 2.26171875
▁diverse 8.8984375
▁groups 1.5634765625
, 1.4130859375
▁the 1.0107421875
▁study 2.669921875
▁used 1.6240234375
▁multiple 4.73046875
▁log 2.875
istic 0.03607177734375
▁regression 0.10174560546875
▁analysis 0.66455078125
▁and 2.537109375
▁chose 8.8984375
▁medical 7.4140625
▁mar 0.32373046875
iju 0.0015077590942382812
ana 0.0001938343048095703
▁as 0.79736328125
▁the 1.0830078125
▁control 2.732421875
▁group 0.5537109375
. 0.28515625
<0x0A> 0.75537109375
This 3.498046875
▁type 6.07421875
▁of 0.00638580322265625
▁study 1.640625
▁is 1.2841796875
▁the 3.416015625
▁most 1.8740234375
▁reve 9.171875
aling 0.0006380081176757812
▁and 1.0556640625
▁inclus 6.44921875
ive 0.0024394989013671875
, 2.328125
▁as 1.8876953125
▁it 0.3564453125
▁contains 4.9453125
▁direct 6.359375
▁responses 4.98828125
▁from 0.82275390625
▁a 3.86328125
▁large 0.9267578125
▁number 0.435302734375
▁of 0.0030879974365234375
▁participants 1.4111328125
. 0.63232421875
▁All 4.6328125
▁tools 9.1328125
▁in 4.55859375
▁the 0.6572265625
▁form 3.515625
▁of 0.040771484375
▁question 1.74609375
na 0.035888671875
ires 9.500980377197266e-05
▁and 2.080078125
▁scales 3.0390625
▁have 3.68359375
▁already 4.4765625
▁been 0.179931640625
▁used 1.935546875
▁and 2.076171875
▁proved 4.2265625
▁their 1.7861328125
▁effic 3.919921875
acy 7.49826431274414e-05
▁for 3.654296875
▁collect 4.60546875
ing 0.0174407958984375
▁analyt 8.265625
ical 0.238525390625
▁data 0.272705078125
. 0.415771484375
▁It 3.53515625
▁helps 4.7734375
▁to 0.9736328125
▁system 7.31640625
at 1.3349609375
ize 0.005828857421875
▁and 1.5791015625
▁class 4.0703125
ify 0.002162933349609375
▁distinct 9.2265625
▁kinds 6.3046875
▁of 0.0240325927734375
▁information 3.427734375
▁for 3.923828125
▁subsequent 4.109375
▁un 8.0078125
comp 5.4140625
licated 0.057373046875
▁services 11.78125
. 0.654296875
▁Thus 4.40625
, 0.0227813720703125
▁research 4.46484375
ers 0.5087890625
▁can 1.3779296875
▁compare 3.962890625
▁the 0.95458984375
▁effects 2.994140625
▁of 0.109619140625
▁medic 4.46875
ations 0.89111328125
▁on 1.8232421875
▁patients 2.07421875
▁of 4.60546875
▁diverse 4.06640625
▁age 2.69921875
▁groups 0.68505859375
, 0.92041015625
▁background 5.01953125
s 0.2054443359375
, 0.06817626953125
▁physical 5.3984375
▁conditions 1.4091796875
, 0.08349609375
▁emot 5.53125
ional 0.0635986328125
▁states 1.3896484375
, 0.10107421875
▁and 0.4345703125
▁so 3.203125
▁on 0.334228515625
. 0.0894775390625
<0x0A> 0.64697265625
The 1.0888671875
▁analysis 4.52734375
▁of 0.58642578125
▁a 5.21875
▁human 9.2890625
▁reaction 5.07421875
▁has 5.15234375
▁a 2.24609375
▁high 3.8984375
▁potential 3.33203125
▁for 0.958984375
▁bias 8.546875
. 1.19921875
<0x0A> 6.0078125
Of 7.41796875
▁the 1.2578125
▁ 1.619140625
8 2.943359375
9 2.662109375
0 2.515625
▁participants 1.1962890625
, 0.76806640625
▁ 0.323486328125
4 1.775390625
7 2.40625
4 2.666015625
▁were 1.236328125
▁treated 4.5625
▁sole 6.10546875
ly 7.319450378417969e-05
▁with 0.515625
▁op 0.8408203125
io 0.399169921875
ids 0.21728515625
, 1.15625
▁ 0.8359375
3 1.0947265625
2 1.74609375
9 2.6484375
▁were 1.453125
▁treated 0.5654296875
▁with 0.271728515625
▁MM 0.443603515625
, 0.207763671875
▁and 0.1368408203125
▁ 0.1517333984375
7 3.5234375
7 2.427734375
▁were 0.791015625
▁treated 0.84326171875
▁with 0.1595458984375
▁place 5.390625
bo 0.4345703125
. 0.29931640625
<0x0A> 1.1103515625
The 1.0947265625
▁study 2.18359375
▁conducted 5.046875
▁a 2.45703125
▁correlation 4.98828125
▁type 7.875
▁of 0.42822265625
▁research 2.28125
▁with 3.072265625
▁variable 8.1640625
▁measures 4.6171875
. 1.1728515625
▁It 2.720703125
▁evaluated 4.23046875
▁the 0.6162109375
▁inter 6.15234375
dep 3.603515625
end 0.0005230903625488281
ence 0.00984954833984375
▁of 0.5
▁various 3.740234375
▁factors 1.404296875
▁that 2.826171875
▁affected 3.712890625
▁the 0.469482421875
▁physical 7.36328125
▁and 0.79443359375
▁emot 0.8232421875
ional 0.0004189014434814453
▁condition 1.0703125
▁of 0.08203125
▁patients 0.8125
▁experien 5.58203125
cing 1.2278556823730469e-05
▁chron 0.759765625
ic 0.0011148452758789062
▁pain 0.028656005859375
. 0.19189453125
▁For 4.62109375
▁example 0.91845703125
, 0.0181427001953125
▁the 1.212890625
▁survey 6.62890625
▁showed 2.958984375
▁that 0.3857421875
▁the 1.591796875
▁ratio 7.10546875
▁of 0.129150390625
▁female 4.78515625
▁patients 0.921875
▁was 1.9296875
▁remark 10.2578125
ably 0.00035834312438964844
▁higher 0.5830078125
▁in 2.548828125
▁the 0.68408203125
▁op 4.4453125
i 4.109375
ates 0.0814208984375
▁group 0.331787109375
▁compared 2.677734375
▁to 0.11419677734375
▁the 0.447021484375
▁MM 0.64306640625
▁group 0.293212890625
. 0.29296875
▁In 3.04296875
▁turn 3.974609375
, 0.002285003662109375
▁people 5.74609375
▁on 5.3515625
▁op 1.8642578125
i 0.572265625
ates 0.0029964447021484375
▁were 1.0458984375
▁more 0.98291015625
▁likely 0.330810546875
▁to 0.049163818359375
▁report 3.001953125
▁major 6.2109375
▁de 0.270751953125
press 1.4091796875
ive 0.00601959228515625
▁dis 0.4560546875
orders 1.24609375
. 1.7421875
<0x0A> 1.3447265625
The 1.0107421875
▁variables 7.3828125
▁used 3.150390625
▁to 1.900390625
▁collect 3.388671875
▁information 2.400390625
▁were 1.390625
▁gender 6.97265625
, 0.14501953125
▁age 0.2841796875
, 0.09429931640625
▁country 5.1796875
, 1.2529296875
▁type 3.6875
▁of 0.055877685546875
▁residence 5.9765625
, 0.08868408203125
▁and 1.6171875
▁years 5.98828125
▁of 0.2147216796875
▁education 1.5986328125
. 0.10650634765625
<0x0A> 1.427734375
Am 6.5390625
ong 0.004726409912109375
▁all 2.8125
▁participants 1.560546875
▁in 3.64453125
▁the 0.1912841796875
▁study 0.328125
, 0.069091796875
▁ 0.4580078125
4 1.8427734375
2 2.703125
. 1.2060546875
2 2.29296875
% 0.18798828125
▁suffered 5.25
▁from 0.09393310546875
▁de 1.2783203125
pression 0.09130859375
, 1.0361328125
▁and 1.611328125
▁ 0.1318359375
3 1.734375
7 2.234375
% 2.654296875
▁experienced 2.568359375
▁excess 7.58984375
ive 0.1571044921875
▁anx 0.1414794921875
iety 0.0018253326416015625
. 0.156494140625
▁The 1.8798828125
▁pl 10.9375
ur 0.7880859375
ality 0.00012123584747314453
▁of 0.206787109375
▁de 3.708984375
press 1.3447265625
ive 0.046539306640625
▁dis 1.978515625
orders 0.0457763671875
▁among 3.552734375
▁patients 1.5634765625
▁in 3.4609375
▁the 0.2205810546875
▁op 1.4267578125
i 0.99951171875
ates 0.004573822021484375
, 6.94921875
▁medical 3.38671875
▁mar 0.045166015625
iju 0.0044403076171875
ana 8.440017700195312e-05
, 0.11834716796875
▁and 0.083984375
▁mixed 8.421875
▁OP 8.78125
MM 7.1171875
▁groups 0.474609375
▁number 7.9453125
ed 0.00830078125
▁ 0.10400390625
5 2.310546875
7 2.576171875
. 0.185546875
1 2.376953125
%, 0.30419921875
▁ 0.00618743896484375
2 2.876953125
2 2.44140625
. 0.130126953125
3 2.224609375
%, 0.1251220703125
▁and 0.024383544921875
▁ 0.00274658203125
5 3.197265625
1 2.5546875
. 0.1854248046875
4 2.150390625
%, 0.378173828125
▁respectively 0.00701141357421875
. 0.050628662109375
▁The 1.8388671875
▁pl 4.15625
ur 0.020782470703125
ality 2.7298927307128906e-05
▁of 0.048858642578125
▁anx 0.7509765625
iety 0.01198577880859375
▁contained 11.453125
▁ 0.53466796875
4 1.6484375
8 2.359375
. 0.06463623046875
4 2.310546875
% 0.53466796875
▁among 1.466796875
▁OP 6.0859375
▁patients 8.546875
, 0.28271484375
▁ 0.1016845703125
2 1.5439453125
1 2.419921875
. 0.1373291015625
5 2.37109375
% 0.0134124755859375
▁among 0.3701171875
▁MM 0.73876953125
▁patients 0.19775390625
, 0.01079559326171875
▁and 0.01146697998046875
▁ 0.037506103515625
3 1.3095703125
8 2.65234375
. 0.1722412109375
7 2.2890625
% 0.01462554931640625
▁among 0.2109375
▁OP 4.26953125
MM 0.327392578125
▁participants 3.298828125
. 0.037811279296875
▁Pat 6.921875
ients 0.02716064453125
▁who 2.515625
▁took 3.060546875
▁strong 7.76171875
▁op 1.7177734375
i 1.3583984375
ates 0.003582000732421875
▁were 1.6689453125
▁t 9.4140625
ended 1.63671875
▁to 0.0172576904296875
▁place 9.984375
▁their 3.52734375
▁pain 3.263671875
▁on 3.30078125
▁a 1.0830078125
▁scale 2.4921875
▁of 0.421142578125
▁ 0.3583984375
9 3.275390625
▁to 1.294921875
▁ 0.014495849609375
1 0.039520263671875
0 0.078857421875
▁( 2.98046875
Fe 10.1484375
ing 6.3671875
old 0.007068634033203125
▁et 1.654296875
▁al 0.0194854736328125
., 0.404296875
▁ 0.012451171875
2 0.23681640625
0 0.0012826919555664062
1 0.48486328125
7 2.103515625
). 0.1337890625
▁They 4.203125
▁were 1.30078125
▁also 1.64453125
▁an 8.6171875
gu 4.58203125
ished 0.03302001953125
▁em 8.0546875
otion 0.00894927978515625
ally 0.0017156600952148438
▁and 1.236328125
▁react 6.9921875
ed 0.050262451171875
▁rad 9.6953125
ically 0.0019626617431640625
▁neg 5.4140625
atively 0.0007104873657226562
▁to 0.39013671875
▁almost 6.02734375
▁all 1.001953125
▁survey 9.5625
▁questions 1.068359375
. 0.250244140625
▁Pat 4.21875
ients 0.0104827880859375
▁who 1.1123046875
▁took 1.25
▁only 5.71875
▁MM 1.5283203125
▁or 3.111328125
▁mixed 4.1640625
▁medic 2.73046875
ations 0.4677734375
▁course 12.734375
▁had 2.376953125
▁a 1.158203125
▁significantly 2.55078125
▁more 4.046875
▁stable 3.802734375
▁emot 1.44140625
ional 0.005847930908203125
▁state 0.91259765625
▁and 1.52734375
▁cop 5.625
ed 0.693359375
▁with 0.7998046875
▁pain 1.5986328125
▁more 1.556640625
▁manage 7.0234375
able 2.9609375
. 0.45166015625
<0x0A> 0.65625
The 1.150390625
▁high 6.36328125
▁response 5.125
▁rate 0.2174072265625
▁is 3.9296875
▁due 3.849609375
▁to 0.025909423828125
▁the 0.326904296875
▁weak 10.25
▁focus 7.5390625
▁of 0.63671875
▁respond 7.30859375
ents 0.11083984375
▁who 4.0234375
▁have 3.802734375
▁overcome 7.5078125
▁severe 2.8046875
▁pain 0.5244140625
▁sens 8.7109375
ations 1.3740234375
▁and 1.369140625
▁de 4.12890625
pression 0.2607421875
. 0.66796875
